Skip to main content

Table 3 Univariable analysis of the impact of severity of illness on treatments administered

From: Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia

 

Risk association

Confidence interval

P value

Beta interferon

– 4.62

−8.40, −0.84

0.018

Alpha interferon

– 1.24

−6.71, 4.24

0.652

Ribavirin

0.78

−3.34,4.90

0.704

Viral treatment

– 5.98

−9.73, −2.23

0.002

Mycophenolate mofetil

– 7.91

−12.90, −2.91

0.003

Hydrocortisone

3.03

−3.62,9.68

0.364

Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us